Complications of endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis

Sanjay Y. Bangarulingam, Andrea A. Gossard, Bret T. Petersen, Beverly J. Ott, Keith Lindor

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Objectives: Endoscopic retrograde cholangiopancreatography (ERCP) is commonly performed in patients with primary sclerosing cholangitis (PSC). The risk of complications associated with this procedure is not well established in these patients. The aim of this retrospective study was to compare the risk of ERCP complications in PSC vs. non-PSC patients.Methods: We identified all Mayo Clinic patients who underwent ERCP in 2005. Procedural and clinical data were collected. Complications were defined as hospitalizations for pancreatitis, cholangitis, perforation, and bleeding.Results: A total of 168 patients with PSC and 981 patients without PSC had at least one ERCP examination in the calendar year 2005. PSC patients were younger (48 years15 vs. 60 years19, P0.000) and had a higher prevalence of portal hypertension (31.5% vs. 4%, P0.0001). PSC patients had more biopsies (39% vs. 15%, P0.0001), brushings (37% vs. 8%, P0.001), balloon dilatations (48% vs. 15%, P0.0001), duct cytology (20% vs. 3%, P0.0001) and intraductal ultrasounds (11% vs. 5%, P0.007) than non-PSC patients. The duration of the procedure was longer in the PSC group (51 min29 vs. 40 min28, P0.0001). The overall rate of complications in patients with PSC when compared to non-PSC patients was not significantly different (18/168 (11%) vs. 76/981(8%), P0.2). The incidence of cholangitis was higher in the PSC group (4% vs. 0.2%, P0.0002) despite routine use of antibiotics before the procedure in PSC patients. The duration of the procedure was longer in PSC patients who developed cholangitis (86 min28 vs. 51 min29, P0.02). The risks of complications such as pancreatitis, perforation, and bleeding were not significantly different between the two groups despite their demographic and procedural variations. The duration of hospitalization due to complications was also not significantly different between the two groups.Conclusions: Complications requiring hospitalizations occur in over 10% of PSC patients undergoing ERCP. Cholangitis occurs more often in PSC patients and correlates with the length of the procedure. Further studies to confirm the role of aggressive prophylactic antibiotics in patients with PSC who undergo prolonged procedures are warranted.

Original languageEnglish (US)
Pages (from-to)855-860
Number of pages6
JournalAmerican Journal of Gastroenterology
Volume104
Issue number4
DOIs
StatePublished - Apr 2009
Externally publishedYes

Fingerprint

Sclerosing Cholangitis
Endoscopic Retrograde Cholangiopancreatography
Cholangitis
Hospitalization
Pancreatitis
Hemorrhage
Anti-Bacterial Agents
Portal Hypertension

ASJC Scopus subject areas

  • Gastroenterology
  • Medicine(all)

Cite this

Complications of endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis. / Bangarulingam, Sanjay Y.; Gossard, Andrea A.; Petersen, Bret T.; Ott, Beverly J.; Lindor, Keith.

In: American Journal of Gastroenterology, Vol. 104, No. 4, 04.2009, p. 855-860.

Research output: Contribution to journalArticle

Bangarulingam, Sanjay Y. ; Gossard, Andrea A. ; Petersen, Bret T. ; Ott, Beverly J. ; Lindor, Keith. / Complications of endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis. In: American Journal of Gastroenterology. 2009 ; Vol. 104, No. 4. pp. 855-860.
@article{648df0ba597a4413a84280aa1d4c0fdb,
title = "Complications of endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis",
abstract = "Objectives: Endoscopic retrograde cholangiopancreatography (ERCP) is commonly performed in patients with primary sclerosing cholangitis (PSC). The risk of complications associated with this procedure is not well established in these patients. The aim of this retrospective study was to compare the risk of ERCP complications in PSC vs. non-PSC patients.Methods: We identified all Mayo Clinic patients who underwent ERCP in 2005. Procedural and clinical data were collected. Complications were defined as hospitalizations for pancreatitis, cholangitis, perforation, and bleeding.Results: A total of 168 patients with PSC and 981 patients without PSC had at least one ERCP examination in the calendar year 2005. PSC patients were younger (48 years15 vs. 60 years19, P0.000) and had a higher prevalence of portal hypertension (31.5{\%} vs. 4{\%}, P0.0001). PSC patients had more biopsies (39{\%} vs. 15{\%}, P0.0001), brushings (37{\%} vs. 8{\%}, P0.001), balloon dilatations (48{\%} vs. 15{\%}, P0.0001), duct cytology (20{\%} vs. 3{\%}, P0.0001) and intraductal ultrasounds (11{\%} vs. 5{\%}, P0.007) than non-PSC patients. The duration of the procedure was longer in the PSC group (51 min29 vs. 40 min28, P0.0001). The overall rate of complications in patients with PSC when compared to non-PSC patients was not significantly different (18/168 (11{\%}) vs. 76/981(8{\%}), P0.2). The incidence of cholangitis was higher in the PSC group (4{\%} vs. 0.2{\%}, P0.0002) despite routine use of antibiotics before the procedure in PSC patients. The duration of the procedure was longer in PSC patients who developed cholangitis (86 min28 vs. 51 min29, P0.02). The risks of complications such as pancreatitis, perforation, and bleeding were not significantly different between the two groups despite their demographic and procedural variations. The duration of hospitalization due to complications was also not significantly different between the two groups.Conclusions: Complications requiring hospitalizations occur in over 10{\%} of PSC patients undergoing ERCP. Cholangitis occurs more often in PSC patients and correlates with the length of the procedure. Further studies to confirm the role of aggressive prophylactic antibiotics in patients with PSC who undergo prolonged procedures are warranted.",
author = "Bangarulingam, {Sanjay Y.} and Gossard, {Andrea A.} and Petersen, {Bret T.} and Ott, {Beverly J.} and Keith Lindor",
year = "2009",
month = "4",
doi = "10.1038/ajg.2008.161",
language = "English (US)",
volume = "104",
pages = "855--860",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Complications of endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis

AU - Bangarulingam, Sanjay Y.

AU - Gossard, Andrea A.

AU - Petersen, Bret T.

AU - Ott, Beverly J.

AU - Lindor, Keith

PY - 2009/4

Y1 - 2009/4

N2 - Objectives: Endoscopic retrograde cholangiopancreatography (ERCP) is commonly performed in patients with primary sclerosing cholangitis (PSC). The risk of complications associated with this procedure is not well established in these patients. The aim of this retrospective study was to compare the risk of ERCP complications in PSC vs. non-PSC patients.Methods: We identified all Mayo Clinic patients who underwent ERCP in 2005. Procedural and clinical data were collected. Complications were defined as hospitalizations for pancreatitis, cholangitis, perforation, and bleeding.Results: A total of 168 patients with PSC and 981 patients without PSC had at least one ERCP examination in the calendar year 2005. PSC patients were younger (48 years15 vs. 60 years19, P0.000) and had a higher prevalence of portal hypertension (31.5% vs. 4%, P0.0001). PSC patients had more biopsies (39% vs. 15%, P0.0001), brushings (37% vs. 8%, P0.001), balloon dilatations (48% vs. 15%, P0.0001), duct cytology (20% vs. 3%, P0.0001) and intraductal ultrasounds (11% vs. 5%, P0.007) than non-PSC patients. The duration of the procedure was longer in the PSC group (51 min29 vs. 40 min28, P0.0001). The overall rate of complications in patients with PSC when compared to non-PSC patients was not significantly different (18/168 (11%) vs. 76/981(8%), P0.2). The incidence of cholangitis was higher in the PSC group (4% vs. 0.2%, P0.0002) despite routine use of antibiotics before the procedure in PSC patients. The duration of the procedure was longer in PSC patients who developed cholangitis (86 min28 vs. 51 min29, P0.02). The risks of complications such as pancreatitis, perforation, and bleeding were not significantly different between the two groups despite their demographic and procedural variations. The duration of hospitalization due to complications was also not significantly different between the two groups.Conclusions: Complications requiring hospitalizations occur in over 10% of PSC patients undergoing ERCP. Cholangitis occurs more often in PSC patients and correlates with the length of the procedure. Further studies to confirm the role of aggressive prophylactic antibiotics in patients with PSC who undergo prolonged procedures are warranted.

AB - Objectives: Endoscopic retrograde cholangiopancreatography (ERCP) is commonly performed in patients with primary sclerosing cholangitis (PSC). The risk of complications associated with this procedure is not well established in these patients. The aim of this retrospective study was to compare the risk of ERCP complications in PSC vs. non-PSC patients.Methods: We identified all Mayo Clinic patients who underwent ERCP in 2005. Procedural and clinical data were collected. Complications were defined as hospitalizations for pancreatitis, cholangitis, perforation, and bleeding.Results: A total of 168 patients with PSC and 981 patients without PSC had at least one ERCP examination in the calendar year 2005. PSC patients were younger (48 years15 vs. 60 years19, P0.000) and had a higher prevalence of portal hypertension (31.5% vs. 4%, P0.0001). PSC patients had more biopsies (39% vs. 15%, P0.0001), brushings (37% vs. 8%, P0.001), balloon dilatations (48% vs. 15%, P0.0001), duct cytology (20% vs. 3%, P0.0001) and intraductal ultrasounds (11% vs. 5%, P0.007) than non-PSC patients. The duration of the procedure was longer in the PSC group (51 min29 vs. 40 min28, P0.0001). The overall rate of complications in patients with PSC when compared to non-PSC patients was not significantly different (18/168 (11%) vs. 76/981(8%), P0.2). The incidence of cholangitis was higher in the PSC group (4% vs. 0.2%, P0.0002) despite routine use of antibiotics before the procedure in PSC patients. The duration of the procedure was longer in PSC patients who developed cholangitis (86 min28 vs. 51 min29, P0.02). The risks of complications such as pancreatitis, perforation, and bleeding were not significantly different between the two groups despite their demographic and procedural variations. The duration of hospitalization due to complications was also not significantly different between the two groups.Conclusions: Complications requiring hospitalizations occur in over 10% of PSC patients undergoing ERCP. Cholangitis occurs more often in PSC patients and correlates with the length of the procedure. Further studies to confirm the role of aggressive prophylactic antibiotics in patients with PSC who undergo prolonged procedures are warranted.

UR - http://www.scopus.com/inward/record.url?scp=65449172444&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65449172444&partnerID=8YFLogxK

U2 - 10.1038/ajg.2008.161

DO - 10.1038/ajg.2008.161

M3 - Article

C2 - 19259076

AN - SCOPUS:65449172444

VL - 104

SP - 855

EP - 860

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 4

ER -